Barely Significant
← all excerpts

The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trial.

EClinicalMedicine · 2019 · PMC6677647 · PMID 31388666

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantp < 0.001actually significant
Highly significant differences were observed between the change in LSaBMD z-scores between the placebo and risedronate groups; 0.274, (95% CI 0.061, 0.487; p < 0.001) and between the risedronate and the alfacalcidol groups; 0.326 (95% CI 0.109, 0.543; p < 0.001) but not between the placebo and alfacalcidol groups; − 0.052 (− 0.257, 0.153).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.